Mountain Capital Investment Advisors’s GSK GSK Stock Holding History

Mountain Capital Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-40,804	Closed	-$2.06M	–	106
2020 Q2	$2.06M	Buy	40,804 +32,938	+419%	+$1.69M	0.94%	20
2020 Q1	$382K	Buy	7,866 +1,324	+20%	+$70.6K	0.2%	30
2019 Q4	$380K	Sell	6,542 -3,107	-32%	-$173K	0.17%	27
2019 Q3	$515K	Buy	9,649 +245	+3%	+$12.6K	0.46%	22
2019 Q2	$478K	Buy	9,404 +1,627	+21%	+$81.6K	0.45%	25
2019 Q1	$406K	Buy	+7,777	New	+$389K	0.44%	22
2017 Q4	–	Sell	-309	Closed	-$16K	–	183
2017 Q3	$16K	Sell	309 -240	-44%	-$12.2K	0.01%	212
2017 Q2	$30K	Buy	+549	New	+$29.3K	0.03%	168

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Mountain Capital Investment Advisors's GSK Position: Q3 2020 in Review

Mountain Capital Investment Advisors sold out of GSK (GSK) in Q3 2020, closing a stake of 40,804 shares — an estimated $2.06M sold.

Mountain Capital Investment Advisors first reported a position in GSK in Q2 2017 and held it in 8 quarters. The position peaked at $2.06M in Q2 2020. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Mountain Capital Investment Advisors reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
Mountain Capital Investment Advisors sold 40,804 GSK shares in Q3 2020, an estimated $2.06M.
Mountain Capital Investment Advisors first reported a position in GSK in Q2 2017 and held it in 8 quarters.
Mountain Capital Investment Advisors's GSK position peaked at $2.06M in Q2 2020.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Mountain Capital Investment Advisors's 13F filing for Q3 2020, filed 13 Oct 2020.